Clinicopathological and prognostic significance of EGFR, VEGF, and HER2 expression in cholangiocarcinoma
Clinicopathological and prognostic significance of EGFR, VEGF, and HER2 expression in cholangiocarcinoma is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Clinicopathological and prognostic significance of EGFR, VEGF, and HER2 expression in cholangiocarcinoma have?
Clinicopathological and prognostic significance of EGFR, VEGF, and HER2 expression in cholangiocarcinoma has 413 citations in the OpenAlex counts ScholarIQ stores.
When was Clinicopathological and prognostic significance of EGFR, VEGF, and HER2 expression in cholangiocarcinoma published?
Clinicopathological and prognostic significance of EGFR, VEGF, and HER2 expression in cholangiocarcinoma has 2007 year in the ScholarIQ index.
What is the open-access status of Clinicopathological and prognostic significance of EGFR, VEGF, and HER2 expression in cholangiocarcinoma?
Clinicopathological and prognostic significance of EGFR, VEGF, and HER2 expression in cholangiocarcinoma has hybrid oa status in the ScholarIQ index.
What is the DOI of Clinicopathological and prognostic significance of EGFR, VEGF, and HER2 expression in cholangiocarcinoma?
The DOI for Clinicopathological and prognostic significance of EGFR, VEGF, and HER2 expression in cholangiocarcinoma is on the source record.
What is the PMID of Clinicopathological and prognostic significance of EGFR, VEGF, and HER2 expression in cholangiocarcinoma?
The PMID for Clinicopathological and prognostic significance of EGFR, VEGF, and HER2 expression in cholangiocarcinoma is on the source record.
What is the OpenAlex record for Clinicopathological and prognostic significance of EGFR, VEGF, and HER2 expression in cholangiocarcinoma?
The OpenAlex for Clinicopathological and prognostic significance of EGFR, VEGF, and HER2 expression in cholangiocarcinoma is on the source record.